We are live on ! Find out more
VTYX

Ventyx Biosciences

Delisted

VTYX was delisted on the 3rd of March, 2026.

138 hedge funds and large institutions have $1.9B invested in Ventyx Biosciences in 2023 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 61 increasing their positions, 44 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

39% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 44

10% more capital invested

Capital invested by funds: $1.73B → $1.9B (+$169M)

2.78% more ownership

Funds ownership: 89.91%92.69% (+2.8%)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

9% less call options, than puts

Call options by funds: $9.34M | Put options by funds: $10.3M

8% less funds holding

Funds holding: 150138 (-12)

43% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 23

Holders
138
Holders Change
-12
Holders Change %
-8%
% of All Funds
2.19%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
13
Increased
61
Reduced
44
Closed
23
Calls
$9.34M
Puts
$10.3M
Net Calls
-$921K
Net Calls Change
+$23.5M
Name Holding Trade Value Shares
Change
Change in
Stake
GTC
76
Ghost Tree Capital
New York
$1.22M +$1.21M +35,000 New
State of Wisconsin Investment Board
77
State of Wisconsin Investment Board
Wisconsin
$1.19M -$370K -10,713 -24%
Wells Fargo
78
Wells Fargo
California
$1.06M -$230K -6,643 -18%
Invesco
79
Invesco
Georgia
$929K +$20.8K +602 +2%
BC
80
Birchview Capital
Vermont
$917K
MAM
81
Martingale Asset Management
Massachusetts
$890K +$333K +9,625 +60%
MIM
82
MetLife Investment Management
New Jersey
$863K
Janney Montgomery Scott
83
Janney Montgomery Scott
Pennsylvania
$853K -$2.56K -74 -0.3%
BG
84
Bellevue Group
Switzerland
$851K
AIG
85
American International Group
New York
$811K +$28.7K +831 +4%
SG Americas Securities
86
SG Americas Securities
New York
$802K +$123K +3,568 +18%
Mirae Asset Global Investments
87
Mirae Asset Global Investments
South Korea
$785K +$2.04K +59 +0.3%
Macquarie Group
88
Macquarie Group
Australia
$782K +$15.2K +439 +2%
SEI Investments
89
SEI Investments
Pennsylvania
$679K +$187K +5,410 +38%
CC
90
Callan Capital
California
$666K
New York State Common Retirement Fund
91
New York State Common Retirement Fund
New York
$662K +$10.2K +296 +2%
ECM
92
Endurant Capital Management
California
$641K +$638K +18,458 New
TRSOTSOK
93
Teachers Retirement System of the State of Kentucky
Kentucky
$600K +$65.6K +1,898 +12%
Allianz Asset Management
94
Allianz Asset Management
Germany
$577K -$201K -5,800 -26%
Jane Street
95
Jane Street
New York
$534K -$1.25M -36,280 -70%
DekaBank Deutsche Girozentrale
96
DekaBank Deutsche Girozentrale
Germany
$529K
CIC
97
Carnegie Investment Counsel
Ohio
$521K
IBT
98
International Biotechnology Trust
United Kingdom
$521K
State Board of Administration of Florida Retirement System
99
State Board of Administration of Florida Retirement System
Florida
$467K +$5.88K +170 +1%
Principal Financial Group
100
Principal Financial Group
Iowa
$445K -$8.33K -241 -2%

VTYX Hedge Fund Activity: Q3 2023 in Review

138 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Ventyx Biosciences (VTYX) for Q3 2023, worth a combined $1.9B — up 9.8% from $1.73B a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of VTYX and 13 opened new positions — a net loss of 10 holders — while 44 trimmed existing stakes and 61 added.

The largest buyer was Adage Capital Partners, adding an estimated $30.9M. The largest seller was Lord, Abbett & Co, cutting an estimated $20.3M.

  • 138 institutional investors held Ventyx Biosciences (VTYX) as of Q3 2023, down from 150 in Q2 2023.
  • Funds reported $1.9B of Ventyx Biosciences stock for Q3 2023, up 9.8% quarter-over-quarter.
  • 13 funds opened new Ventyx Biosciences positions in Q3 2023 and 23 closed out, a net change of -10 holders.
  • The largest Ventyx Biosciences buyer in Q3 2023 was Adage Capital Partners, an estimated $30.9M added.
  • The largest Ventyx Biosciences seller in Q3 2023 was Lord, Abbett & Co, an estimated $20.3M sold.

Based on aggregated 13F filings for Q3 2023.